BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 22, 2001
View Archived Issues
Medical Discoveries' MDI-P shows efficacy as microbicide in preclinical studies
Read More
Ivax updates proprietary product pipeline
Read More
Meditech licenses Solaraze from SkyePharma
Read More
Drospirenone-containing contraceptive first launched in Germany
Read More
January launch for MyoBloc injectable solution for cervical dystonia
Read More
Corixa and CoPharma enter collaboration for novel cardioprotectant
Read More
CVT's phytopharmaceutical for cold and flu enters phase II
Read More
Generex completes joint venture with Elan
Read More
Schering-Plough submits two new applications for desloratadine in the E.U.
Read More
Patient enrollment complete in phase I/II Chrysalin trial
Read More
Wyeth-Ayerst seeks FDA approval of new indication of Alesse
Read More
Potential new therapy for erectile dysfunction presented by Dong-A
Read More
FDA denies approval of Aronex's Atragen for APL
Read More
Ciba Vision pharmaceutical unit is now Novartis Ophthalmics
Read More
Maxim's NDA for histamine hydrochloride deemed unapprovable by FDA
Read More
Modex completes patient enrollment in EpiDex phase II trial
Read More
Biogen's Avonex meets primary endpoint in study of secondary progressive MS
Read More
Genzyme General begins treating Fabry's disease patients; global disease registry launched
Read More
Two new clinical trials commence with Genasense for leukemia
Read More
Patent issued to Sigma-Tau covering L-carnitine or alkanoyl derivatives and statin combinations
Read More
Genentech describes new series of DR4 modulators for cancer and immune-related diseases
Read More
Sankyo presents new anti-HIV agents
Read More
MMP inhibitors from Pfizer reportedly useful for inflammatory disorders and cancer
Read More
Celltech Group claims new series of squaric acid derivatives
Read More
Novel tachykinin NK1 receptor antagonists disclosed by Roche
Read More